Infectious - Bionauts

2024-07-02 3:36 pm

Production method for LNP to increase mRNA drug expression efficiency

Lipid nanoparticles produced using Solvent X in the solvent dilution method achieved about 10-fold luciferase expression in vivo when administered.

2024-07-02 3:10 pm

Neuroregenerative therapy with neuraminidase inhibitors

Induces migration of newly generated neurons to the injured area by improving the microenvironment of injured brain tissue.

2025-10-14 12:00 pm

Stem Cell Differentiation/Undifferentiation Stabilizing Reagent for High Quality Manufacturing

Botulinum non-toxic hemagglutinin(bHA) fragment controls E-cadherin cell-cell adhesion

2024-06-05 9:43 am

Next-Generation Diagnostic Method for Predicting Treatment Response and Prognosis

A novel method for examining pathological tissue that quantitatively analyzes interactions between multiple proteins in tumor tissue using the proprietary developed IBMseq

2024-10-08 10:16 am

MASH Fibrosis Biomarkers

Diagnosis of liver fibrosis in MASH using serum IgA protein bound A2Fbisect glycans and their precursor glycans as biomarkers

2025-09-24 10:55 am

Treatment for Ciliopathies, Retinitis Pigmentosa

Improvement of cilial dysfunction by FGFR inhibitor through ICK/MAK pathway activation.

2024-05-22 11:44 am

Simple and Highly Accurate Vibration Characteristic Measurement System

A vibration measurement system that applies an excitation force close to the ideal by hitting with a small soft bullet instead of an impact hammer.

2024-05-19 11:56 pm

aHUS Differential Diagnosis Method/Kit

Diagnostic kit for differentially diagnosing atypical hemolytic uremic syndrome (aHUS) from other thrombotic microangiopathy (TMA) using blood tests.

2024-05-19 11:52 pm

Sub-Acute Phase Treatment for CNS Injury-Recovery by Autologous Cell Transplantation

Oral tissue-derived neural cell therapy for stroke and spinal cord injury.

2024-05-19 11:46 pm

Selective Medium for Carbapenem-Non-Susceptible Viridans Group Streptococci

Identification method and selection medium for viridans group streptococci (VGS) resistant/non-susceptible to β-lactam antibiotics including carbapenems.